PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry and Molecular Biology, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.\', \'Divisions of Pulmonary, Critical Care and Sleep Medicine, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.\', \'Department of Cardiology, Houston Methodist Hospital, Houston, TX 77030, USA.\', \'Division of Pulmonary and Critical Care Medicine, Brigham and Women\'s Hospital and Harvard Medical School, Boston, MA 02115, USA.\', \'Co-Director, Pulmonary Vascular Diseases Center, The Methodist Hospital, Houston, TX 77030, USA.\', \'Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX 77030, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • E808110.3390/ijms21218081
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 33138181
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all